Single Session Intervention for Building Self-Compassion Habits-RCT

May 14, 2022 updated by: Allison Harvey, University of California, Berkeley

A Single Session Intervention Leveraging an Ultra-Brief Exercise for Building Self-Compassion Habits-A Randomized Controlled Trial

The study will test a single session self-compassion intervention that leverages an ultra-brief contemplative exercise. It will evaluate the effect of this intervention on psychopathology, stress, growth mindset, positive affect, self-compassion and the automaticity of self-compassion, as well as the relationships between these constructs and the automaticity of self-compassion. The participants will be undergraduate students at a large public university.

Study Overview

Detailed Description

The broad aims of the proposed research is to examine the outcomes of a single session psychological intervention and to further understand processes and factors associated with habit formation. undergraduate students at a large university will be randomly assigned to a self-compassion intervention (SCI), or an active control (AC), and complete assessments at baseline (pre-treatment) and 4 weeks later (post-treatment).

The investigators seek to examine the following: (A1) Determine whether the group who receives the SCI, relative to the AC, will experience increased self-compassion, growth mindset and positive affect, as well as reduced stress and psychopathology. (A2) Evaluate whether the SCI group shows greater increases in automaticity of self-compassion compared to the AC pre- to post-treatment. (A3) Assess whether greater pre- to post-treatment increases in automaticity of self-compassionate are associated with increased self-compassion, growth mindset, and positive affect, as well as reductions in stress and psychopathology.

The investigators hypothesize the following: (H1) SCI will promote greater increases in self-compassion, growth mindset, and positive affect, as well as greater reductions in stress and psychopathology from pre- to post-treatment, relative to AC. (H2) The SCI group will show greater increases in the automaticity of self-compassion than AC from pre- to post-treatment. (H3) Greater increases in the automaticity of self-compassion from pre- to post-treatment will be predicted by greater increases in self-compassion, growth mindset, and positive affect, as well as greater decreases in psychopathology and stress, from pre- to post treatment. To further understand the results obtained, the investigators will evaluate participants' frequency, adherence, and impressions of using the intervention.

Study Type

Interventional

Enrollment (Actual)

135

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Berkeley, California, United States, 94720-1650
        • University of California at Berkeley

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years of age or older.
  • English language proficiency.
  • Able and willing to give informed consent.

Exclusion Criteria:

  • Does not have email address or access to email.
  • Not able/willing to participate in and/or complete the pre-treatment assessments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Self-Compassion Intervention (SCI)
First, participants will be taught to implement a 20-second self-compassion induction via video recording. Second, participants will be taught to choose a cue that will precede their daily use of the self-compassion induction. Participants will document the cue they chose, and will be emailed a record of their selected cue, along with the recording and transcript of the self-compassion induction that they can refer back to for reference. Third, participants will be asked to use the self-compassion induction as much as they can and at least once during their daily routine following exposure to their chosen cue.
This 20-second contemplative exercise includes draws from the science of habit formation and includes elements of self-soothing touch, somatic experiencing, and mindful self-compassion.
Active Comparator: Finger-Tapping Active Control (AC)
The active control will receive the same procedures as described above, except for receiving a different video containing different instructions describing a finger-tapping exercise. The videos will be virtually identical in length, quality, instructor/their outfit, and lighting.
This 20-second finger tapping exercise involves touching each finger to the thumb on one hand and repeating for twenty seconds. This intervention was designed to control for the potential effect of assessment on outcomes, the effect of having an activity to do for the duration of the intervention (4 weeks), regression to the mean, time, or other nonspecific factors.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sussex-Oxford Compassion for the Self Scale (SOCS-S)
Time Frame: Change from baseline to post-treatment (week 4)

Sum of 20-item, 5-point response scale. Scores can range from 20 to 100 (Higher score means higher compassion for self).

Sub-scale items included.

Change from baseline to post-treatment (week 4)
Kind of Person' Implicit Theory Scale (KOPITS)
Time Frame: Change from baseline to post-treatment (week 4)

8 items. 6-point response scale (1 = strongly agree; 6 = strongly disagree) Higher scores indicate a more growth mindset. Lower scores indicate a more fixed mindset.

Score is sum of all items, with Q3, Q5, Q7, and Q8 reverse-scored. The formula for reverse-scoring an item is: ((Number of scale points) + 1) - (Respondent's answer)

Change from baseline to post-treatment (week 4)
Positive and Negative Affect Schedule (PANAS)
Time Frame: Change from baseline to post-treatment (week 4)

10 items with a 6 point response scale. Positive affect sub-scale only.

Scoring:

Positive Affect Score: Sum score of 1, 3, 5, 9, 10, 12, 14, 16, 17, and 19. Scores range from 10 - 50. Higher scores = higher levels of positive affect.

Negative Affect Score: Sum score of 2, 4, 6, 7, 8, 11, 13, 15, 18, and 20. Scores range from 10 - 50. Lower scores = lower levels of negative affect.

Change from baseline to post-treatment (week 4)
10-item Perceived-Stress Scale (PSS-10)
Time Frame: Change from baseline to post-treatment (week 4)

10 items, 5 point response scale (from 0 = Never to 4 = Very Often)

Scoring: Reverse score (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) items 4, 5, 7, & 8 and then summing across all scale items.

Change from baseline to post-treatment (week 4)
DSM-5 Cross-Cutting Measure (DSM-XC)
Time Frame: Change from baseline to post-treatment (week 4)
22 items (suicidality item Q11 removed). 5-point scale (0=none or not at all; 1=slight or rare, less than a day or two; 2=mild or several days; 3=moderate or more than half the days; and 4=severe or nearly every day).
Change from baseline to post-treatment (week 4)
Self-Report Behavioral Automaticity Index for Self-Compassion
Time Frame: Change from baseline to post-treatment (week 4)
20 items. 1-9 scale.
Change from baseline to post-treatment (week 4)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State Self-Compassion Scale Long Form (SSCS-L)
Time Frame: Change from pre-induction to post-induction at baseline and at post-treatment (week 4). Change in pre to post-induction changes in state self-compassion from baseline to post-treatment (week 4)
9 items. 1-5 scale. Scores range from 9-45. Mindfulness, common humanity, and self-kindness sub-scales only.
Change from pre-induction to post-induction at baseline and at post-treatment (week 4). Change in pre to post-induction changes in state self-compassion from baseline to post-treatment (week 4)
Self-Report Behavioral Automaticity Index for Exercise
Time Frame: Change from baseline to post-treatment (week 4)
4 items. 1-9 scale.
Change from baseline to post-treatment (week 4)
Real Self Overlap Scale
Time Frame: Change from baseline to post-treatment (week 4)
1 item. 1-8 scale.
Change from baseline to post-treatment (week 4)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Practice Frequency
Time Frame: Assessed at Post-treatment (week 4)
Number of times practiced self-compassion exercise per day. 1 item.
Assessed at Post-treatment (week 4)
Overall Practice Frequency
Time Frame: Assessed at Post-treatment (week 4)
Number of days in the past two months that did not practice the exercise at all. 1 item.
Assessed at Post-treatment (week 4)
Practice Duration
Time Frame: Assessed at Post-treatment (week 4)
1 item, number of days practiced exercise but for less than 10 seconds.
Assessed at Post-treatment (week 4)
Adherence Report Scale
Time Frame: Assessed at Post-treatment (week 4)
10 items on a five-point scale, where 5 = never, 4 = rarely, 3 = sometimes, 2 = often and 1 = always. Scores for each item were summed to give a total score, with higher scores indicating higher levels of reported adherence.
Assessed at Post-treatment (week 4)
General impressions of exercise
Time Frame: Assessed at Post-treatment (week 4)
Exploratory qualitative assessment.
Assessed at Post-treatment (week 4)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eli S Susman, BA, University of California, Berkeley

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2022

Primary Completion (Actual)

April 29, 2022

Study Completion (Actual)

April 29, 2022

Study Registration Dates

First Submitted

January 5, 2022

First Submitted That Met QC Criteria

January 5, 2022

First Posted (Actual)

January 20, 2022

Study Record Updates

Last Update Posted (Actual)

May 17, 2022

Last Update Submitted That Met QC Criteria

May 14, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-12-14924

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transdiagnostic Psychopathology

Clinical Trials on Single Session Intervention Leveraging an Ultra-Brief Self-Compassion Exercise

3
Subscribe